Sandusky, Ohio--(Newsfile Corp. - October 29, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced adding a nutraceutical development pathway to its existing pharmaceutical cannabis drug development strategy. Last week, PAOG announced a master services agreement with a clinical research organization (CRO) in the U.S. to prepare PAOG for...